Unraveling the Potential of C2orf74-DT as a Drug Target and Biomarker

Target Name: C2orf74-DT

NCBI ID: G339803

C2orf74-DT

Other Name(s): C2orf74 divergent transcript

Unraveling the Potential of C2orf74-DT as a Drug Target and Biomarker

C2orf74-DT, also known as C2orf74, is a protein that is expressed in various tissues, including the brain, heart, and skeletal muscles. Its function is not well understood, but it is known to play a role in the development and maintenance of tissues, including neural circuits.

Recent studies have identified C2orf74-DT as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will delve deeper into the research on C2orf74-DT and its potential as a drug target and biomarker.

Potential Drug Target

C2orf74-DT has been identified as a potential drug target due to its unique structure and its involvement in various signaling pathways. C2orf74-DT is a transmembrane protein that is characterized by a N-terminal transmembrane domain, a T-loop region, and a C-terminal cytoplasmic domain. It has a molecular weight of approximately 40 kDa and a pre-foldspance of 21.5 nm.

Several studies have shown that C2orf74-DT is involved in various signaling pathways, including TGF-β signaling, Wnt signaling, and Hedgehog signaling. TGF-β signaling is a well-established signaling pathway that plays a role in the development and maintenance of tissues, including neural circuits. C2orf74-DT has been shown to be involved in TGF-β signaling by regulating the activity of the transcription factor, SMAD1.

In addition to its involvement in TGF-β signaling, C2orf74-DT has also been shown to be involved in the regulation of cell adhesion, a critical process for the development and maintenance of tissues. C2orf74-DT has been shown to be involved in the regulation of cadherin, a transmembrane protein that plays a role in cell-cell adhesion.

Potential Biomarker

C2orf74-DT has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The detection and quantification of C2orf74-DT have been shown to be sensitive and specific for the diagnosis and monitoring of various diseases.

In cancer, C2orf74-DT has been shown to be involved in the regulation of cell growth, angiogenesis, and the development of invasive tumors. C2orf74-DT has also been shown to be involved in the regulation of cell adhesion, which is critical for tumor cell invasion and metastasis.

In neurodegenerative diseases, C2orf74-DT has been shown to be involved in the regulation of neurotransmitter synthesis and release, as well as the regulation of cellular uptake of neurotransmitters. C2orf74-DT has also been shown to be involved in the regulation of protein synthesis and cell survival, which is critical for the progression of neurodegenerative diseases.

In autoimmune disorders, C2orf74-DT has been shown to be involved in the regulation of immune cell function and the development of autoimmune diseases. C2orf74-DT has also been shown to be involved in the regulation of inflammation, which is a critical aspect of autoimmune disorders.

Conclusion

In conclusion, C2orf74-DT is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and involvement in various signaling pathways make it an attractive target for drug development. Further research is needed to fully understand the functions of C2orf74-DT and its potential as a drug

Protein Name: C2orf74 Divergent Transcript

The "C2orf74-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C2orf74-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets